Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cerilliant
Dow
Julphar
Queensland Health
Chinese Patent Office
Daiichi Sankyo
McKinsey
Medtronic

Generated: January 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021229

« Back to Dashboard

NDA 021229 describes PRILOSEC OTC, which is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the PRILOSEC OTC profile page.

The generic ingredient in PRILOSEC OTC is omeprazole magnesium. There are one hundred and thirty-one drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the omeprazole magnesium profile page.
Summary for 021229
Tradename:PRILOSEC OTC
Applicant:Astrazeneca Pharms
Ingredient:omeprazole magnesium
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021229
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229 NDA The Procter & Gamble Manufacturing Company 37000-455 37000-455-01 1 TABLET, DELAYED RELEASE in 1 POUCH (37000-455-01)
PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229 NDA The Procter & Gamble Manufacturing Company 37000-455 37000-455-02 1 BLISTER PACK in 1 CARTON (37000-455-02) > 14 TABLET, DELAYED RELEASE in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, DELAYED RELEASE;ORALStrengthEQ 20MG BASE
Approval Date:Jun 20, 2003TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 15, 2019Product Flag?Substance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Nov 3, 2019Product Flag?Substance Flag?Delist Request?

Expired US Patents for NDA 021229

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229-001 Jun 20, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229-001 Jun 20, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229-001 Jun 20, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
McKesson
Harvard Business School
Dow
Colorcon
US Department of Justice
QuintilesIMS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.